Bionano Genomics
BNGO
152 hedge funds and large institutions have $548M invested in Bionano Genomics in 2021 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 37 increasing their positions, 22 reducing their positions, and 31 closing their positions.
135% more first-time investments, than exits
New positions opened: 73 | Existing positions closed: 31
68% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 22
57% more capital invested
Capital invested by funds: $349M → $548M (+$199M)
43% more call options, than puts
Call options by funds: $59.3M | Put options by funds: $41.5M
38% more funds holding
Funds holding: 110 → 152 (+42)
11.29% more ownership
Funds ownership: 15.51% → 26.8% (+11%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$98.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$48.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$36.6M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$19.9M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$19.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$76.7M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$26.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15.6M |
| 4 |
HF
HRT Financial
New York
|
-$7.52M |
| 5 |
Jane Street
New York
|
-$4.74M |
BNGO Hedge Fund Activity: Q2 2021 in Review
152 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q2 2021, worth a combined $548M — up 57% from $349M a quarter earlier.
Buyers outnumbered sellers: 73 funds opened new BNGO positions and 31 closed out — a net gain of 42 holders — while 37 added to existing stakes and 22 trimmed.
The largest buyer was BlackRock, adding an estimated $98.1M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $76.7M sold.
- 152 institutional investors held Bionano Genomics (BNGO) as of Q2 2021, up from 110 in Q1 2021.
- Funds reported $548M of Bionano Genomics stock for Q2 2021, up 57% quarter-over-quarter.
- 73 funds opened new Bionano Genomics positions in Q2 2021 and 31 closed out, a net change of +42 holders.
- The largest Bionano Genomics buyer in Q2 2021 was BlackRock, an estimated $98.1M added.
- The largest Bionano Genomics seller in Q2 2021 was Renaissance Technologies, an estimated $76.7M sold.
Based on aggregated 13F filings for Q2 2021.